Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group.

Source:http://linkedlifedata.com/resource/pubmed/id/20629979

Download in:

View as

General Info

PMID
20629979